LEXICON PHARMACEUTICALS, INC. (LXRX) Operating income 2016–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) annual operating income history from SEC filings — each fiscal year as reported.
-$48.9MFY2025 · since FY2016: -$127.2M → -$48.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$48.9M | +75.2% |
| FY2024 | -$197.1M | -14.8% |
| FY2023 | -$171.8M | -70.5% |
| FY2022 | -$100.8M | -15.7% |
| FY2021 | -$87.1M | -82.2% |
| FY2020 | -$47.8M | -133.8% |
| FY2019 | $141.4M | +237.0% |
| FY2018 | -$103.3M | +20.9% |
| FY2017 | -$130.6M | -2.7% |
| FY2016 | -$127.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice